Clinical Trials · NCT04048707

Angiotensin 2 for Hepatorenal Syndrome

Name: Angiotensin 2 for Hepatorenal Syndrome
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

WithdrawnPhase 2Octreotide

Phase: Phase 2
Recruitment status: Withdrawn
Sponsor: University of California, Los Angeles
Enrollment: 0
Start date: Jul 2021
Locations: See registry
Primary endpoint: Reversal of hepatorenal syndrome

View Octreotide compound reference